Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?
Laoudi
Y
Y
Paolini
J-B
JB
Grimfed
A
A
Just
J
J
D000280:Administration, Inhalation; D000293:Adolescent; D000666:Amphotericin B / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000150:complications / Q000188:drug therapy*; D019819:Budesonide / Q000008:administration & dosage*; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D009330:Nebulizers and Vaporizers; D012138:Respiratory Therapy
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D019819:Budesonide; D000666:Amphotericin B